Canbi  Pharma  Tech  Cyfyngedig
540737-29-9 tofacitinib sitrate

540737-29-9 tofacitinib sitrate

Cas: 540737-29-9
MF: C16H20N6O.C6H8O7
MW: 504.497
EINECS: 638-826-4
MDL Rhif:mfcd11616529

Anfon ymchwiliad
Disgrifiad

Eiddo
Pwynt toddi: 201 gradd (dadelfennu)
Temp Storio. temp ystafell
hydoddedd dmso: hydawdd5mg/ml (datrysiad clir; wedi'i gynhesu)
Ymddangosiad gwyn i bowdr llwydfelyn

 

Cais:

Mae Tofacitinib (cp -690550) Citrate yn atalydd JAK3 newydd gydag IC50 o 1 nm, ac mae ei ddetholusrwydd tuag at JAK2 a JAK1 20 i 100 gwaith yn is.

 

Cyfystyron:

Tofacitinib sitrate

540737-29-9

Tasocitinib sitrate

XeljanzCity name (optional, probably does not need a translation)

Tofacitinib (cp -690550) sitrate

Tofacitinib (sitrad)

Tasocitinib monocitrate

Tofacitinib monocitrate

3- ((3r, 4r) {-4- methyl -3- (methyl (7h-pyrrolo [2, {3- d] pyrimidin -4- yl) amino) piperIdin 2- hydroxypropane -1, 2, 3- tricarboxylate

{1- piperidinepropanenitrile, {4- methyl -3- (methyl {-7 H-pyrrolo (2, {3- d) pyrimidin {}, 4r, 4 2- hydroxy -1, 2, 3- propanetricarboxylate (1: 1)

2- hydroxypropane -1, 2, 3- asid tricarboxylic; 3- [(3r, 4r) -4- methyl -3- [methyl ({7h-pyrrolo [2, 3- d] pyr imidin -4- yl}) amino] piperidin -1- yl] -3- oxopropanenitrile

2- hydroxypropane -1, 2, 3- tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile

3- ((3r, 4r) {-4- methyl -3- (methyl (7h-pyrrolo (2, 3- d) pyrimidin {{}} yl) amino) amino) Idin -1- yl) -3- oxo-propanenitrile 2- hydroxypropane -1, 2, 3- tricarboxylate (1: 1)

3- ((3r, 4r) {-4- methyl -3- (methyl (7h-pyrrolo (2, 3- d) pyrimidin {{}} yl) amino) piperidin}}}}}}} 2- hydroxypropane -1, 2, 3- tricarboxylate

3- {(3r, 4r) -4- methyl -3- [methyl (methyl (7h-pyrrolo [2, {3- d] pyrimidin {{}} yl) amino] pibro 2- hydroxypropane -1, 2, 3- tricarboxylate

3- {(3r, 4r) -4- methyl -3- [methyl- (7h-pyrrolo [2, 3- d] pyri midin -4- yl) -amino] -piperidin -1- yl} -3- oxo-propionitrile halen sitrad

3- {(3r, 4r) -4- methyl -3- [methyl- (7h-pyrrolo [2, 3- d] pyri midin -4- yl} -amino] -piperidin -1- yl) -3- oxo-propionitrile halen sitrad

Xeljanz (TN)

Xeljanzxr

Halen asid citrig tasocitinib

Tofacitinib Citrate [Ion]

C16H20N6O.C6H8O7

SyikufDoyjfGBQ-YLAFAASESA-N

Tofacitinib (sitrad) (safonol)

Tofacitinib monocitrate [mi]

Citrate Tofacitinib [WHO-DD]

AKOS022178222

Tofacitinib citrate, >(HPLC)

Tofacitinib Citrate [Llyfr Oren]

CP 690550 Citrate (tofacitinib sitrate)

Citrate tofacitinib (cp -690550 sitrate)

(3r, 4r) -4- methyl -3- (methyl -7 H-pyrrro lo [2, 3- d] pyrimidin -4- ylamino) -beta-oxo {}}}} oddi

(3r, 4r) -4- methyl -3- (methyl -7 H-pyrrolo [2, 3- d] pyrimidin -4- ylamino) -beta-oxo {}}}}}}}}}}}}}}}} 2- hydroxy -1, 2, 3- propanetricarboxylate

1- piperidinepropanenitrile, {4- methyl -3- (methyl -7 H-pyrrolo (2, 3- d) pyrimidin {{7} ylamin. 2- hydroxy -1, 2, 3- propanetricarboxylate

 

Tagiau poblogaidd: 540737-29-9 Tofacitinib Citrate, China 540737-29-9 Gwneuthurwyr Citrate Tofacitinib, Cyflenwyr

Inquiry
goTop

(0/10)

clearall